** Shares of Compumedics CMP.AX fall 5% to A$0.285, their biggest intraday pct loss since May 6
** The medical device maker lowers its revenue forecast for FY26 to a range of A$50 million ($32.20 million)- A$55 million, compared to its previous outlook of A$55 million
** Also sees FY26 EBITDA of about A$3 million, lower than earlier forecast of A$5 million
** Co attributes lowered guidance to the lag between reported revenues and sales orders taken for its Somfit device
** YTD, shares up 7.6%
($1 = 1.5528 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。